BEERSE, Belgium, January 4, 2011 /PRNewswire/ — Janssen-Cilag International NV today announced that it has receivedapproval from the European Commission for the first antipsychotic treatmentfor schizoaffective disorder. INVEGA(R) (paliperidone ER) is now indicatedfor the treatment of psychotic or manic symptoms of schizoaffective disorder.Effect on depressive symptoms has not been demonstrated. The decision follows a positive [...]